Roslin-2 activates p53 in _p53 +/+_ HCT116 cells, suppressing tumor growth and inducing p21 activation. This effect is not observed in _p53 -/-_ cells or tumors, as demonstrated in HCT116 mouse xenograft models at a dose of 60 mg/kg.